NO20051393L - Prosess og intermediater for fremstilling av tienopyrrol-derivater - Google Patents
Prosess og intermediater for fremstilling av tienopyrrol-derivaterInfo
- Publication number
- NO20051393L NO20051393L NO20051393A NO20051393A NO20051393L NO 20051393 L NO20051393 L NO 20051393L NO 20051393 A NO20051393 A NO 20051393A NO 20051393 A NO20051393 A NO 20051393A NO 20051393 L NO20051393 L NO 20051393L
- Authority
- NO
- Norway
- Prior art keywords
- intermediates
- preparation
- thienopyrrole
- derivatives
- thienopyrrole derivatives
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Tienopyrolderivater
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222912.8A GB0222912D0 (en) | 2002-10-03 | 2002-10-03 | Novel process and intermediates |
| PCT/GB2003/004217 WO2004031194A1 (en) | 2002-10-03 | 2003-09-29 | Process and intermediates for the preparation of the thienopyrrole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051393L true NO20051393L (no) | 2005-04-20 |
Family
ID=9945219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051393A NO20051393L (no) | 2002-10-03 | 2005-03-16 | Prosess og intermediater for fremstilling av tienopyrrol-derivater |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7411074B2 (no) |
| EP (1) | EP1549654A1 (no) |
| JP (1) | JP2006505541A (no) |
| KR (1) | KR20050061503A (no) |
| CN (1) | CN100378106C (no) |
| AU (1) | AU2003269219A1 (no) |
| BR (1) | BR0314966A (no) |
| CA (1) | CA2500145A1 (no) |
| GB (1) | GB0222912D0 (no) |
| MX (1) | MXPA05003327A (no) |
| NO (1) | NO20051393L (no) |
| WO (1) | WO2004031194A1 (no) |
| ZA (1) | ZA200502340B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0222909D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
| BRPI0418244A (pt) | 2003-12-29 | 2007-04-17 | Sepracor Inc | composto, métodos para aumentar a concentração de d-serina e/ou diminuir a concentração de produtos tóxicos da oxidação de d-serina pela daao em um mamìfero, para tratar a esquizofrenia, para tratar ou prevenir a perda de memória e/ou cognição associadas com o mal de alzheimer, para tratar a ataxia ou para prevenir a perda da função neuronal caracterìstica de doenças neurodegenerativas, para intensificar a aprendizagem, memória e/ou cognição e para tratar dor neuropática, e, composição farmacêutica |
| AU2007205114B2 (en) | 2006-01-06 | 2012-11-08 | Sunovion Pharmaceuticals Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
| ES2566479T3 (es) | 2006-01-06 | 2016-04-13 | Sunovion Pharmaceuticals Inc. | Inhibidores de reabsorción de monoamina con base en tetralona |
| US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| CN103936605B (zh) | 2007-05-31 | 2017-09-01 | 赛诺维信制药公司 | 苯基取代的环烷胺作为一元胺再摄取抑制剂 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU364613A1 (ru) * | 1970-11-27 | 1972-12-28 | Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе | Способ получения производных 2-аминотиено- |
| JPH01242587A (ja) * | 1988-03-25 | 1989-09-27 | Sankyo Co Ltd | 縮環オキサゾロチエノピリミジン誘導体 |
| GB9302622D0 (en) | 1993-02-10 | 1993-03-24 | Wellcome Found | Heteroaromatic compounds |
| PT1088824E (pt) | 1999-09-30 | 2004-04-30 | Pfizer Prod Inc | Pirrolil-amidas biciclicas como inibidores de glicogenio-fosforilase |
| WO2001028993A2 (en) | 1999-10-19 | 2001-04-26 | Merck & Co. Inc. | Tyrosine kinase inhibitors |
| SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| JP2001294572A (ja) | 2000-02-09 | 2001-10-23 | Dai Ichi Seiyaku Co Ltd | 新規スルホニル誘導体 |
| EP1136071A3 (en) | 2000-03-22 | 2003-03-26 | Pfizer Products Inc. | Use of glycogen phosphorylase inhibitors |
| GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| GB0021831D0 (en) * | 2000-09-06 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| MXPA03000966A (es) | 2002-02-28 | 2003-09-04 | Pfizer Prod Inc | Agentes antidiabeticos. |
| GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| AU2003227360A1 (en) | 2002-04-25 | 2003-11-10 | Yamanouchi Pharmaceutical Co., Ltd. | Novel amide derivatives or salts thereof |
| DK1543011T3 (da) * | 2002-09-06 | 2006-08-07 | Janssen Pharmaceutica Nv | Thienopyrrolyl- og furanopyrrolylforbindelser og deres anvendelse som histamin H4-receptorligander |
| GB0222909D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
| WO2004041780A2 (en) | 2002-11-07 | 2004-05-21 | Pfizer Products Inc. | N-(indole-2-carbonyl) amides as anti-diabetic agents |
| US7098235B2 (en) * | 2002-11-14 | 2006-08-29 | Bristol-Myers Squibb Co. | Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| JP2004196702A (ja) | 2002-12-18 | 2004-07-15 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド誘導体又はその塩 |
| AU2003292828B9 (en) | 2002-12-25 | 2009-10-01 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| WO2004092158A1 (en) | 2003-04-17 | 2004-10-28 | Pfizer Products Inc. | Carboxamide derivatives as anti-diabetic agents |
| MXPA05011702A (es) * | 2003-04-30 | 2006-01-23 | Pfizer Prod Inc | Agentes antidiabeticos. |
| WO2004113345A1 (ja) | 2003-06-20 | 2004-12-29 | Japan Tobacco Inc. | 縮合ピロール化合物及びその医薬用途 |
| GB0318463D0 (en) | 2003-08-07 | 2003-09-10 | Astrazeneca Ab | Chemical compounds |
| GB0318464D0 (en) | 2003-08-07 | 2003-09-10 | Astrazeneca Ab | Chemical compounds |
| GB0319759D0 (en) | 2003-08-22 | 2003-09-24 | Astrazeneca Ab | Chemical compounds |
| GB0319690D0 (en) | 2003-08-22 | 2003-09-24 | Astrazeneca Ab | Chemical compounds |
| WO2005020985A1 (en) | 2003-08-29 | 2005-03-10 | Astrazeneca Ab | Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| WO2005020986A1 (en) | 2003-08-29 | 2005-03-10 | Astrazeneca Ab | Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity |
| GB0320422D0 (en) | 2003-08-30 | 2003-10-01 | Astrazeneca Ab | Chemical compounds |
-
2002
- 2002-10-03 GB GBGB0222912.8A patent/GB0222912D0/en not_active Ceased
-
2003
- 2003-09-29 CA CA002500145A patent/CA2500145A1/en not_active Abandoned
- 2003-09-29 AU AU2003269219A patent/AU2003269219A1/en not_active Abandoned
- 2003-09-29 EP EP03750995A patent/EP1549654A1/en not_active Withdrawn
- 2003-09-29 MX MXPA05003327A patent/MXPA05003327A/es not_active Application Discontinuation
- 2003-09-29 US US10/528,974 patent/US7411074B2/en not_active Expired - Fee Related
- 2003-09-29 BR BR0314966-8A patent/BR0314966A/pt not_active Application Discontinuation
- 2003-09-29 CN CNB038236176A patent/CN100378106C/zh not_active Expired - Fee Related
- 2003-09-29 WO PCT/GB2003/004217 patent/WO2004031194A1/en not_active Ceased
- 2003-09-29 KR KR1020057005618A patent/KR20050061503A/ko not_active Withdrawn
- 2003-09-29 JP JP2004540943A patent/JP2006505541A/ja active Pending
-
2005
- 2005-03-16 NO NO20051393A patent/NO20051393L/no unknown
- 2005-03-18 ZA ZA200502340A patent/ZA200502340B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060035953A1 (en) | 2006-02-16 |
| ZA200502340B (en) | 2005-09-19 |
| WO2004031194A1 (en) | 2004-04-15 |
| MXPA05003327A (es) | 2005-07-05 |
| GB0222912D0 (en) | 2002-11-13 |
| AU2003269219A1 (en) | 2004-04-23 |
| CA2500145A1 (en) | 2004-04-15 |
| KR20050061503A (ko) | 2005-06-22 |
| CN100378106C (zh) | 2008-04-02 |
| US7411074B2 (en) | 2008-08-12 |
| BR0314966A (pt) | 2005-08-02 |
| CN1688587A (zh) | 2005-10-26 |
| JP2006505541A (ja) | 2006-02-16 |
| EP1549654A1 (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
| ATE495162T1 (de) | Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung | |
| CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
| SG147409A1 (en) | Amide derivatives | |
| SG141459A1 (en) | Novel quinoline derivatives | |
| SG143985A1 (en) | Quinolinone derivatives | |
| SG143986A1 (en) | Substituted phenylsulfonamide inhibitors of beta amyloid production | |
| GEP20105036B (en) | Perindopril | |
| NO20051393L (no) | Prosess og intermediater for fremstilling av tienopyrrol-derivater | |
| ITTO20030629A1 (it) | Procedimento di realizzazione di collegamenti ad | |
| NO20043842L (no) | Nye krystallformer av atorvastatinhemikalsium og fremgangsmater for fremstilling derav, savel som nye fremgangsmater for fremstilling av atorvastatinhemikalsiumform I, VIII og IX | |
| TW200508233A (en) | Chk-1 inhibitors | |
| EE05428B1 (et) | Protsess ülipuhta perindopriili ja sünteesi kasulike vaheühendite valmistamiseks | |
| PL394821A1 (pl) | Sposób wytwarzania kombrestatyn | |
| AU2003299227A1 (en) | Synthesis of amines and intermediates for the synthesis thereof | |
| MY138550A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| EA200501900A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| EA200501925A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| NO20052859D0 (no) | Fremgangsmate for fremstilling av resperidon og intermediater derav | |
| MY143244A (en) | Calcilytic compounds | |
| EA200600456A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| AU2003216848A1 (en) | Deracemisation of amines | |
| MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| AU2003229459A1 (en) | Methods of using thiazolidinedithione derivatives | |
| SG144942A1 (en) | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |